The development of MM manifestations from premalignant states such as MGUS or SMM requires a second DNA lesion or loss of cell cycle surveillance and repairing systems such as chromosome 16 methylation, MYC abnormalities, and RAS and p53 mutations [6]. Here, MYC is linked to Miyoshi myopathy.